BioPharma, Pharma GSK and Vir Terminate Influenza Alliance a Year After Ending Covid-19 R&D Pact By Frank Vinluan
BioPharma, Pharma At JPM, Top GSK Cancer Executive Talks Drug Targets and Oncology Strategy By Frank Vinluan
BioPharma, Pharma GSK Drug Pulled From Market Beats J&J Multiple Myeloma Med in Phase 3 Test By Frank Vinluan
BioPharma, Pharma Contamination Risk Sparks a Recall of GSK, Scynexis Antifungal Drug By Frank Vinluan
BioPharma, Pharma FDA Approves GSK Myelofibrosis Med That Has Edge Over Others in Drug Class By Frank Vinluan
BioPharma, Pharma GSK Patent Suit Aims to Halt Pfizer’s RSV Vaccine for Adults, But Not Infants By Frank Vinluan
BioPharma, Pharma Pfizer’s RSV Vaccine Wins FDA Approval on Heels of Regulatory Nod for GSK By Frank Vinluan
BioPharma, Pharma GSK Strikes Another Antimicrobial Deal, Paying $90M for Scynexis’s Brexafemme By Frank Vinluan
BioPharma, Pharma GSK’s Covid-19 Valentine to Vir Biotech: ‘You Can Go Your Own Way’ By Frank Vinluan
BioPharma, Pharma GSK Gets FDA Nod for Drug Treating Anemia From Chronic Kidney Disease By Frank Vinluan
BioPharma, Pharma Merck’s $1.3B Imago Buyout Brings Blood Cancer Drug to Rival BMS, Incyte & GSK By Frank Vinluan
Artificial Intelligence, BioPharma GSK Digital & Tech Executive Takes Drug-Hunting Inspiration from Outer Space By Frank Vinluan
